People running a business for profit and for this, they use all their resources to the fullest. However, because of increasing competition, today, to take calculated risks to achieve their business targets. Here, money also plays an important role as a “money attracts more money”. You need to have money to sustain your business and meet all business needs, as well, on time. On the one hand, finance can be regarded as the backbone of any business. However, there are bad times when you may need quick cash to meet sudden business obligations. As long as the business scenario, to reach a financial institution becomes need of hour, and very often, they ask you for collateral. If you do not have collateral to pledge and are confident that in the near future your business conditions will improve, then get a business loans without collateral just the right step for your business. No doubt, unsecured loans business have many advantages, such as there is no risk of repossession of assets, rapid process credits, payment options are convenient and tax deductible interest payments. Before you sign up for an unsecured loan for your business, you need a business plan to show the lender money. The business plan is helpful in convincing the lender that his money would be easily restored back in time.

Please sharing and discussion. Hopefully Indonesia increased women’s health and cancer can be prevented.

Alcohol abuse, has a scar on the lungs (bronchiectasis), and emphysema associated with actinomycosis. Actinomycosis in the lungs causes lung cavities, spots on lungs, and pleural effusion. The disease is rare in any age, but most patients are aged 30-60 years. Men get this infection more often than women do.

Cause:

Pulmonary actinomycosis is caused by one of two types of bacteria – actinomyces or propioni.

symptoms:

Chest pain when taking deep breaths
coughing up phlegm
drain sinus
fever
lethargy
Night sweats
shortness of breath
Weight loss

treatment:

The goal of treatment is to control the infection. However, many patients take a long time to get better conditions. Patients should receive penicillin through a vein (intravenously) for 4 to 6 weeks to heal, followed by the eating of penicillin by mouth for several months. While the surgery was needed to drain the fluid from the lungs and infection control.

One thing that we all know is that we live in an ever-changing world that is filled with stress. There is no way that we can escape it no matter what we do or where we go, there are pressures in life that we all must learn to deal with. These things can raise your blood pressure, increase your heart rate and cause you to lose your cool. Stress will affect you in one way or another, but it doesn’t have to conquer you and take a toll on your health.

Recent studies that have been conducted by scientists have shown that stress is the root cause of most of the deadly diseases that are killing men and women. The good news is that even though stress is unavoidable, there are steps that you can take to put it at a level that will not affect your health in a negative way. There are some unusual ways that you can use to control stress so you can carry on with your everyday life.

One of the main causes of stress is lack of sleep. When you do not get a good night’s sleep, you wake up cranky and grumpy and that is because while you are sleeping, your body is repairing itself. If you cheat yourself on sleep there is a good chance that your bodily organs will not function properly and your head will become clouded and you will lose your focus and you will easily get stressed. You can easily avoid this by getting to bed early. It is a proven fact that the best times for your body to repair damaged tissues and cells is between the hours of 10pm and 6am. Make a habit of being in bed by 10pm so your body will get enough sleep and rest.

Diet is another factor that affects how you deal with stress. There are certain foods that can help ease stress. Having an omelet for breakfast can help clear your brain so you can focus and concentrate better. The reason for this being that these foods are high in tyrosine which is an amino acid that helps to improve focus and alertness along with helping you with the ability to do multiple tasks at the same time. Sesame seeds are another food that helps to fight stress because they contain a form of amino acid called L-arginine. This type of acid works to help the blood vessels to relax, so if you are not having a good day, try some sesame seeds or some other type of nuts such as cashews, soybeans or peanuts as all of these also contain L-arginine.

Apples are another way to fight stress and keep it away. They are not only a healthy food that will boost your body’s health, they will also combat stress and fatigue. They are very rich in antioxidants and they can help to jump-start your system when you are feeling tired and stressed and best of all, they taste good!

Along with getting the proper amount of sleep and eating a nutritious diet, perhaps the most important way of fighting stress is through exercise. Even though exercising is not a pleasing thing to do, it has many benefits besides burning fat and building muscles. Most important of all, it is the quickest way to improve your mood and to eliminate your stress. When you exercise, your brain releases a form of chemical called endorphins. They have the ability to give your mood a boost so you will remain positive throughout the day.

The best thing that you can do is to not let stress rule your life and by applying these methods, you can achieve the upper hand and live a healthier life.

I hope that you enjoyed this article and if you would like some great free tips on eating healthy, than please visit my site where you will find some great information to help you live a long and healthy life.

]]> http://www.iahq.org/2011/12/21/improve-your-health-by-fighting-stress/feed/ 120 http://www.iahq.org/2011/12/14/brand-versus-generic-medication-costs-fact-and-fiction-within-cholesterol-medication/ http://www.iahq.org/2011/12/14/brand-versus-generic-medication-costs-fact-and-fiction-within-cholesterol-medication/#comments Wed, 14 Dec 2011 14:40:06 +0000 salman http://www.iahq.org/?p=43

There is an aggressive push to substitute brand medication use with generic counterparts. Such can be found from the insurance companies, pharmacies and government.

The New England Journal of Medicine (NEJM) weighs in with a recent contribution – Generic Atorvastatin and Health Care Costs – NEJM.

The aforementioned provides a savings analysis with regard to projected generic medication use of atorvastatin. However, the analysis is made somewhat moot since overall consideration is not given to the increase in costs on the medical benefits end – when persons with non typical metabolism need repeated visits to the doctor or hospitalization as a result of their switch from brand medication to the generic counterpart.

When insisting upon substituting generic medication in the place of already utilized brand medication, those who insist have utilized narrowly defined cost savings’ analysis. One restricted to the confines of pharmacy benefits – without analysis of the resulting increase on medical benefits side of the equation when generic medications do not provide equal therapeutic response as compared to the brand medication counterpart.

Generic Atorvastatin focuses disappointment upon the fact that substandard quality in another country’s generic manufacturing facility caused delay of the production of a generic atorvastatin – and alongside the delay Pfizer had found a way to market its own branded Lipitor as a generic counterpart, at reduced cost to the consumer.

What becomes of patient care when those in the medical establishment seem to hold significant negative focus upon big pharma’s ability to creatively market products at reduced price to the consumer?

In Generic Atorvastatin, alongside mention of the cost savings that has already been realized by the consumer due to Pfizer’s creative marketing of its own product – the article complains that fictional savings are not being realized (according to the article model). Pfizer decided to let the consumer save – and this was not figured into the article’s projected savings model, therefore it is hard pressed to wholly consider the already realized consumer savings as a good thing. Said another way, big pharma is bad.

Even when the consumer wins – cost wise – the mantra seems to continue; big pharma is bad and generic pharma is good. However, they are all are in it to make money. Big pharma, generic pharma and even the local pharmacy are going to make money from the purchase of medication. The local pharmacy is making quite a profit from sale of generics. Makers of generic medications have historically pulled shenanigans in order to drive up the cost of the generic medication product.

Big pharma has funded research and initial development – as the original innovators – of generic counterparts. Your local pharmacy and generic manufacturers are simply piggy backing off of big pharma, and then experiencing substantial profit while doing so.

For those in the medical establishment a more important focus – than the undercurrent of their issues with big pharma – would be to focus upon the non typical metabolizer’s response to generic medications that are comprised of lower quality ingredients. Indifference seems to be present with regard to consideration for those who cannot respond favorably to generic medication. Those in need of a most careful and precise delivery of medication are being lobbied against at every turn – it appears, even by NEJM’s contributors.

From within every pertinent agency and the medical establishment, need come more thoughtful scrutiny with regard to interactive trends on both sides of the cost equation; pharmacy benefits and medical benefits. Differing experts and agencies have not delved into the medical benefit ramifications of the very strong leanings toward rote use of generic medications. Most simply like to stand upon the Food and Drug Administration’s (FDA) safe and equivalent rating of generics, and they also like to represent that generics are exactly the same as brand.

The equivalent rating amounts to word play, because the FDA rating allows for 20 percent difference in delivery of the active ingredients – in a normal subject – and this is necessary because the FDA is allowing a differing medication composition. The regulatory agency is comfortable with the fact that – in normal subjects – the 20 percent delivery difference does not make all that much of a therapeutic difference in performance. This kind of equivalency should bring no comfort for the many that do not metabolize normally.

Generic medication delivery difference can profoundly alter therapeutic response because of the use of differing bulking agents, preservatives, coatings. The generic medications also have differing shelf life instabilities and manufacturer glitches.

With regard to the safe and equivalent rating that is given by the FDA – the agency ensures that drugs are safe and effective when used as directed. Generic drugs that show they are bioequivalent to the brand name drug – in normal subjects – are considered to be as safe and effective as the brand name drug according to the parameters in which the FDA has confined their generic support. The FDA parameters do not include consideration of the non typical metabolizer.

The FDA equivalency rating has resulted in negating the physicians’ ability to prescribe appropriately and this is more than likely causing an increase in medical benefits costs to the insurance companies – and ultimately the consumer.

Doctors’ attempts to properly apply medical treatments have already begun to suffer due to the narrow view of pharmacy benefit savings, presented as an overall societal good. Medical treatments have been confounded and have taken a step backward. All the while, the process of regulating generic medications has also gone backward.

Generic drug makers have not been required to incorporate the same safety and efficacy tests as the original brand name manufacturers (innovators) in order to be granted FDA approval – since the mid 1980s. Legislation has allowed for an abbreviated FDA approval process that only involves normal subjects who would be less prone toward non typical metabolism issues. Generic companies are granted approval for marketing their product simply by submitting results from studying healthy volunteers with regard to their typical absorption response; a response less likely for those who are most in need of precise delivery of medications.

The FDA safe and equivalent rating of generic medications has put a chink in the armor of protection standards while also confusing the issue of medical necessity for patients. Insurance companies, pharmacies and policy makers have taken the safe and equivalent rating and run with it, without comprehensively understanding the rating’s unintended consequence; a significantly larger increase in costs on the medical benefits side of the equation.

The generic medication is always equal and better argument does not suit every person. At some point those in the aforementioned fields need to include wisdom in their push for utilization of generic medication. In experiences with my daughter and mother I have seen that the generic argument can actually be costly and dangerous for those most vulnerable.

According to Generic Atorvastatin, model Pfizer’s Lipitor patent expired in June 2011, with the first generic version entering the market on November 30, 2011. The article’s cost savings projections hoped that Lipitor’s generic counterpart – Atorvastatin – would dominate the statin market by 3 years after market entry at 44% market share. However, Pfizer’s marketing strategies seem to have frustrated the article model. Hopefully this generic product will be comprised of quality ingredients that offer efficient delivery for the non typical metabolizer.

Atorvastatin has been thought to have an association with myopathy – for those with less typical metabolization response there would be bigger risk for overall side effects.

Joseph Mercola writes:

That these drugs have proliferated the market the way they have is a testimony to the power of marketing, corruption and corporate greed, because the odds are very high- greater than 100 to 1-that if you’re taking a statin, you don’t really need it. The ONLY subgroup that might benefit are those born with a genetic defect called familial hypercholesterolemia, as this makes them resistant to traditional measures of normalizing cholesterol. And, even more importantly, cholesterol is NOT the cause of heart disease.

Given the aforementioned odds of those taking a statin who do not really need them…such odds would really provide significant costs savings on the pharmacy benefits end of the equation if the people who are needlessly taking statins simply discontinued.

Mercola also recommends the use of CoQ10 if a person is taking a statin.

****